Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See
full details
.
I Agree
×
Join today and have your say! It’s FREE!
Join Now
Sign In
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.
Join Today
or
Sign in with existing account
Privacy Policy
|
Disclaimer
Sign In
Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Remember me
Forgot Password?
Sign In
or
Sign Up
Privacy Policy
|
Disclaimer
Please Try Again
{{ error }}
Send my password
Submit
Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Linking with Facebook:
Stockhouse membership requires an email address which must be shared by Facebook.
By default, joining or signing in using your Facebook account will work and the email address will be shared by Facebook automatically.
If you change your Facebook permissions to restrict Stockhouse from receiving your email while joining or signing in to Stockhouse then it will fail.
Please do not modify the permission settings during sign-in.
Sign in with Facebook
Return to Signup Options
Home
Community
Bullboards
Blogs
Groups
Messages
Markets
Stocks
TSX
TSXV
CSE
Cboe Canada
NASDAQ
NYSE
NYSE American
Cryptocurrency
Currencies
Market Movers
Bonds
News
Featured News
Trending News
Canadian Press Releases
US Press Releases
Video
Editorial
Thematic Insights
Independent Reports
Interviews
Buzz on the Bullboards
Portfolio
Watchlist
Portfolio
Showcase Companies
DealRoom
Quote
|
Bullboard
|
News
|
Opinion
|
Profile
|
Peers
|
Filings
|
Financials
|
Options
|
Price History
|
Ratios
|
Ownership
|
Insiders
|
Valuation
Bullboard - Stock Discussion Forum
Sirona Biochem Corp
V.SBM
Alternate Symbol(s):
SRBCF
Healthcare
Biotechnology
Sirona Biochem Corp. is a cosmetic ingredient and drug discovery company with a proprietary technology platform developed at its laboratory facility in France with a specialization in the stabilization of carbohydrate molecules. The Company is exploring the areas of diabetes, dyschromia, anti-aging, anti-cellulite and antiviral therapies and relies on a business model of licensing patents to...
large organizations in return for up-front and milestone payments as well as royalties. Its two most advanced programs are the cosmetic skin lightener and diabetes drug. The Company's TFC-1067 is for the treatment of Dyschromia (Dark spots on the skin). GlycoProteMim is a novel anti-aging compound. GlycoProteMim is based on the naturally occurring glycoproteins found in Antarctic fish, known to protect them against environmental stressors. It is focused on three current antiviral categories: Neuraminidase Inhibitors, Nucleoside Analogs and Iminosugars. Its wholly owned subsidiary is TFChem S.A.R.L.
see more
Join the community and start posting on the bullboards today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Create a portfolio watchlist today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Add To Watchlist
Bullboard (TSXV:SBM)
New Post
View:
Posts & Comments
Threaded Posts
Prev
...
221
222
223
224
225
226
227
228
229
230
231
232
233
234
235
236
237
238
239
240
...
Next
(1064)
•••
Pandora
X
View Profile
View Bullboard History
Comment by
Pandora
on Jul 09, 2022 7:57pm
RE:RE:RE:Do you feel like you've been had again.
Certainly doesn't show that way. Do you have some evidence they did?
(1064)
•••
Pandora
X
View Profile
View Bullboard History
Comment by
Pandora
on Jul 09, 2022 7:15pm
RE:Do you feel like you've been had again.
Last Insider action -- way back in January?? As of 11:59pm ET July 9th, 2022 Filing Date Transaction Date Insider Name Ownership Type
...more
Discover Options Trading Strategies to Minimize your Tax Burden
posted Dec 01, 2024 9:00am by
Bank of Montreal
-
|
Options trading doesn’t come without tax implications, but there are ways investors can still optimize their after-tax returns with just a little bit of understanding. Approaches for investors to keep in mind are holding periods, wash-sales rule, tax advantaged accounts, and qualified cover calls. BMO’s enhanced InvestorLine platform. Industry-leading tools and capabilities specifically designed to empower options traders. ...read more
(72)
•••
MirrorWorldMan
X
View Profile
View Bullboard History
Comment by
MirrorWorldMan
on Jul 07, 2022 5:52pm
RE:RE:RE:AbbVie lowers Q2 and FY 2022 guidance on acquired R&D assets
$200MM is not unusual for Big Pharma to pay a bunch of white coats for the rights to their molecules. Novartis paid that to a small group of 10 scientists 2 decades ago for the rights to 3 C-Reactive
...more
(77)
•••
Pareto8020
X
View Profile
View Bullboard History
Comment by
Pareto8020
on Jul 07, 2022 11:56am
RE:RE:AbbVie lowers Q2 and FY 2022 guidance on acquired R&D assets
How sad is it that shareholders have to grind through mandatory financial disclosures to even judge the impact of a "watershed"....."epic "......"company making" deal
...more
(72)
•••
MirrorWorldMan
X
View Profile
View Bullboard History
Comment by
MirrorWorldMan
on Jul 07, 2022 11:48am
RE:AbbVie lowers Q2 and FY 2022 guidance on acquired R&D assets
Nice find Turtle, maybe Abbvies financial notes will delail the IPR&D's
(101)
•••
biorun
X
View Profile
View Bullboard History
Comment by
biorun
on Jul 07, 2022 11:15am
RE:Bio-runs, are you now a proponent of Covid Vacination?
Interesting the perspective here. Did you know that 2 million Canadians think birds are a hoax? https://twitter.com/acoyne/status/1539604600042520580?s=21&t=wRODgTwA58AOI1k1snQ-9w
(25)
•••
PutinKhuylo1
X
View Profile
View Bullboard History
Comment by
PutinKhuylo1
on Jul 07, 2022 11:05am
RE:RE:RE:RE:RE:RE:RE:Upfront Fee Material Information?
It'll be a 10-Q and should come quickly after earnings release, which is assumed July 28-August 1.
(75)
•••
forhandlaren
X
View Profile
View Bullboard History
Comment by
forhandlaren
on Jul 07, 2022 10:47am
RE:RE:RE:RE:RE:RE:Upfront Fee Material Information?
Interesting remark about the upcoming Abbvie 10K report. Any chance you know the date?
(80)
•••
bealert
X
View Profile
View Bullboard History
Post by
bealert
on Jul 07, 2022 10:44am
Bio-runs, are you now a proponent of Covid Vacination?
Exerpt from one of Bio-runs later posts shown below: Note Anti-vaxxers will not understand that one, ie the scientific facts. Not only are you accomplished at advising us on this board, but you also
...more
(101)
•••
biorun
X
View Profile
View Bullboard History
Comment by
biorun
on Jul 07, 2022 10:26am
RE:RE:RE:RE:RE:RE:RE:Upfront Fee Material Information?
yes, at a minimum for Canada as I understand. if there are future milestone payments, those may not as they are forward looking and conditional. at year end, most of details may also have to be tabled
...more
(25)
•••
PutinKhuylo1
X
View Profile
View Bullboard History
Post by
PutinKhuylo1
on Jul 07, 2022 10:24am
ABBV 8-K
LOL, dreamin', but did we cause this? From yesterday's ABBV filed 8-K warning about a hit to earnings. Item 2.02 Results of Operations and Financial Condition Reported
...more
(30)
•••
jimmyhorizon
X
View Profile
View Bullboard History
Comment by
jimmyhorizon
on Jul 07, 2022 10:20am
RE:RE:RE:RE:RE:RE:Upfront Fee Material Information?
thank you. To be clear. If they had received, let's say, 10m upfront in their account last week, then they would only have to disclose this in the next quarterly figures? is that
...more
(101)
•••
biorun
X
View Profile
View Bullboard History
Comment by
biorun
on Jul 07, 2022 10:16am
RE:RE:RE:Risk for further dilution?
yes, I agree with these points but it is possible at this point that the share price will not reach 0.60 and these outstanding warrants can be the equivalent offset in number of shares re: dilution I
...more
(101)
•••
biorun
X
View Profile
View Bullboard History
Comment by
biorun
on Jul 07, 2022 10:11am
RE:RE:RE:RE:RE:Upfront Fee Material Information?
yes, they are required to report all money coming into the coffers as you indicate, but abbvie also has to report a 10k in august where they "may" also be required to disclose certain
...more
Prev
...
221
222
223
224
225
226
227
228
229
230
231
232
233
234
235
236
237
238
239
240
...
Next
Thank You
Your Report has been submitted.
Report Abusive Content
×
Close
Sign up to get access
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
The Market Update
{{currentVideo.title}}
{{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >
A daily snapshot of everything
from market open to close.
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}
{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >